Threshold Pharmaceuticals (THLD) Widens Q1 Loss to $2.12/Share
Get Alerts THLD Hot Sheet
Join SI Premium – FREE
Threshold Pharmaceuticals (NASDAQ: THLD) reported Q1 EPS of ($2.12), versus ($0.23) reported last year.
For earnings history and earnings-related data on Threshold Pharmaceuticals (THLD) click here.
For earnings history and earnings-related data on Threshold Pharmaceuticals (THLD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share